Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
This study has been completed.
Study NCT00273039   Information provided by GlaxoSmithKline

First Received on January 5, 2006.   Last Updated on May 31, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anxiety Disorders
Social Anxiety Disorder
Additional conditions recognized in this trial
Phobic Disorders
More general conditions related to this trial
Mental Disorders
Interventions listed in this trial
paroxetine
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services